Omar Mian, MD, PhD

Appointed
2016

Education & Fellowships

Residency - Johns Hopkins Hospital
Radiation Oncology
Baltimore, MD USA
2016

Internship - Virginia Commonwealth University
Internal Medicine
Richmond, VA USA
2012

Medical Education - Virginia Commonwealth University Medical College
Richmond, VA USA
2011

Graduate School - Johns Hopkins University
Baltimore, MD USA
2001

Undergraduate - James Madison University
Harrisonburg, VA USA
1998

Additional Training

• 2014 ASCO/AACR Methods in Clinical Cancer Research Workshop, Vail, CO
• 2015 AACR Molecular Biology in Clinical Oncology Workshop, Aspen, CO

Professional Highlights

• 2014-2015 Research Fellow, Radiation Oncology, Johns Hopkins University
• 2014-2015 Vice Chair, Housestaff Council, Johns Hopkins Hospital
• 2016-2017 Clinical, Translational and Basic Science Advisory Subcommittee Member, ASTRO
• 2016-2021 Promoting Science through Education Subcommittee Member, ASTRO
• 2017-Present Radiation and Cancer Biology Course Director, Cleveland Clinic
• 2020-Present NCCN Panel Member

Certifications

• Radiology - Radiation Oncology

Awards & Honors

• 2007 Alpha Omega Alpha Honor Medical Society
• 2007 VCU Research Retreat, 1st Place Poster
• 2007 Phi Kappa Phi Honor Society
• 2008 Golden Key Honor Society
• 2008 C.C. Clayton Outstanding Student Award, Molecular Biology and Genetics Program
• 2008 AMA Seed Grant, American Medical Association
• 2008 Massey Cancer Center Symposium, Excellence in Cancer Research, 1st Place Award
• 2009 American College of Physicians, VA Associates Meeting, 1st Place Poster
• 2009 Phi Kappa Phi Love of Learning Award
• 2014 Brachytherapy Next Meeting Travel Award
• 2015 1st place, Clinical Translation Research, SKCCC Fellow’s Research Retreat
• 2016 RSNA Roentgen Resident/Fellow Research Award
• 2019 CCF Radiation Oncology Educator of the Year 
• 2021 National Comprehensive Cancer Network (NCCN) Young Investigator Award
• 2021 Society of Basic Urologic Research (SBUR) Young Investigator Award
• 2021 American Cancer Society Research Scholar Award
  

Innovations & Patents

• Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes , US Patent office; Patent number: 7998682; 2011/8/16

Memberships

• 2013 American Brachytherapy Society (ABS)
• 2012 American Society for Radiation Oncology (ASTRO)
• 2012 American Society of Clinical Oncology (ASCO)
• 2012 American Board of Radiology (ABR)
• 2009 American Association for Cancer Research (AACR)

See publications for Omar Mian, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/19/2023, Dr. Mian has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Mian receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• The American Society of Clinical Oncology

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.